openPR Logo
Press release

Global Antihypertensive Drugs Market Study Analysis: Hypertension is becoming ever more prevalent all over the globe will Boost the Antihypertensive Drugs Market's Growth

02-10-2022 02:23 PM CET | Health & Medicine

Press release from: Evolve Business Intelligence

Global Antihypertensive Drugs Market Study Analysis:

The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 4.87% during the forecast period. Hypertension is a medical condition that results in a rise in blood pressure in the arteries. Hypertension may lead to numerous serious complications including heart failure, aneurysm, heart attacks, and dementia. To prevent the serious effects of hypertension early diagnosis and treatment are required. Furthermore, hypertension may cause cardiovascular, renal, or endocrine disorders. Antihypertensive drugs are used to treat hypertension. Hypertension is caused due to unhealthy diets that include excessive salt consumption, a diet high in saturated fat and trans fats, and low intake of fruits and vegetables, physical inactivity, consumption of tobacco and alcohol, and being overweight or obese. Some common antihypertensive drugs available are cardiovascular, renal, or endocrine disorders. These drugs are a combination of several compounds that prevent, control or treat hypertension by reducing cardiovascular morbidity and mortality. According to World Health Organization’s report, there are 1.13 billion people worldwide suffering from hypertension. The increasing geriatric population, changing lifestyle, and rise in population are expected to drive the antihypertensive market growth.

To request a free sample, Go To: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=006883

Global Antihypertensive Drugs Drivers And Restrain:
The major factors that have impacted the growth of the antihypertensive drugs market are increasing investments for research for more effective antihypertensive drugs, and the adoption of combination therapies that will enhance the capacity of antihypertensive drugs, among others.

Increasing investments for research:
Hypertension results in various other health issues like kidney diseases, narrowed blood vessels in the eyes, and metabolic syndromes. The available medicines for hypertension are not much effective and have various side effects due to the complications associated with uncontrolled high blood pressure According to World Health Organization 1 in 5 people have the hypertension problem under control and also hypertension is one of the major causes of premature death worldwide. This data states that there is a requirement for better drugs for curing hypertension. Thus, the governments and private drug manufacturers are undertaking a significant amount of R&D investments to discover novel antihypertensive drugs that can treat hypertension with better efficiency than the available drugs. The rise in continual research in this field will thus be anticipated to contribute towards the anti-hypertension market growth in the coming years.

Adoption of Combination Therapies:
The use of a combination of two or more antihypertensive drugs to cure hypertension is expected to be the most prominent medication type. The combination medicines will prove efficient in patients who have fluctuating blood pressure or are at a higher cardiovascular risk to attain the desirable outcome and reduce the risk of other side effects. The benefits of combination therapy include greater efficacy, improved response rates, better tolerability, favorable pharmacokinetics, improved compliance, and possibly low cost. Several research in the area of combination therapies in the antihypertensive drugs market is likely to increase to achieve therapeutic goals.
The market is hampered by blockbuster medication patents are running out.

Impact Of COVID-19 on the Antihypertensive Drugs Market:
• Impact on Market Size
• End-User Trend, Preferences, and Budget Impact
• Regulatory Framework/Government Policies
• Key Players Strategy to Tackle Negative Impact
• Opportunity Window

Global Antihypertensive Drugs Market Segments:
The global Antihypertensive Drugs market is further segmented into type, product, distribution channel, and geography.
By Therapeutic Class: Diuretics, Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, Beta Blockers, Alpha Blockers, Renin Inhibitors, Calcium Channel Blockers, and Others
By Type: Primary Hypertension, and Secondary Hypertension

By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, and Online Stores
Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
• Rest of the World (the Middle East & Africa and South America)

North America is anticipated to dominate the antihypertensive drugs market growth owing to an increasing number of patients with hypertension and a rise in the geriatric population. Moreover, the government and health organization are running various programs for spreading awareness hypertension and presence of advanced healthcare infrastructure are also expected to supplement the antihypertensive drugs market growth in this region. Asia-Pacific is estimated to significantly contribute to the antihypertensive drugs market due to rising awareness towards the use of antihypertensive drugs and the emerging life sciences industry.

Key Players of Global Antihypertensive Drugs Market:
• AstraZeneca
• Johnson & Johnson Services Inc
• Merck & Co Inc
• Novartis
• Pfizer Inc
• Sanofi
• Bayer
• Cipla
• Daiichi Sankyo Company
• Boehringer Ingelheim

For Any Query or Customization, Ask Our Industry Experts@https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=006883

Key Questioned Answered Through The Report:
• The Impact of COVID-19 on the global market
• What are the potential opportunities for new entrants in the global market
• What is the market Size and Forecast from 2020 to 2028?
• Key Players associated with the global Antihypertensive Drugs Market
• Value Chain Analysis of Global Antihypertensive Drugs Market
• What is the CAGR of the global Antihypertensive Drugs Market from 2021 to 2028
• Major Growth Factor, Challenges, Trends, and Opportunities in the global market
• Key outcomes of SWOT Analysis

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Contact: +1 773 644 5507 / +91 635 396 3987
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is market research, business intelligence, and advising service that offers creative solutions to a company's problems. Data beneficial to micro, small, medium, and large-scale businesses can be found in our market research studies. We offer a wide range of services, from data collection to business consulting.
Evolve Business Intelligence is built on account of technology advancement and our in-house AI-modelled data analysis and forecast tool – EvolveBI – provides extremely accurate data. This application tracks real-time statistics from Fortune's Global 2000 firms, including quarterly performance, annual performance, and recent changes.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Antihypertensive Drugs Market Study Analysis: Hypertension is becoming ever more prevalent all over the globe will Boost the Antihypertensive Drugs Market's Growth here

News-ID: 2549823 • Views:

More Releases from Evolve Business Intelligence

Capsules: Encapsulating Opportunity in the Self-Healing Concrete Market
Capsules: Encapsulating Opportunity in the Self-Healing Concrete Market
The self-healing concrete market is gaining momentum, driven by the need for durable and sustainable infrastructure. Within this innovative field, the capsule segment stands out as a high-opportunity area, offering a promising approach to automatically repair rifts and extend the lifespan of concrete structures. Market Dynamics and Growth Drivers Capsule-based self-healing concrete incorporates micro or macro capsules containing healing agents, such as bacteria, polymers, or mineral precursors, into the concrete mix. When
Flow and Level Sensors: Navigating High Opportunity in the Marine Sensors Market
Flow and Level Sensors: Navigating High Opportunity in the Marine Sensors Market
The marine sensors market is experiencing significant growth, driven by the increasing demand for enhanced vessel safety, operational efficiency, and environmental monitoring. Among the diverse array of marine sensors, the flow and level sensors segment presents a high-opportunity area, playing a vital role in ensuring optimal vessel performance and preventing critical failures. Market Dynamics and Growth Drivers Flow and level sensors provide real-time data on fluid levels and flow rates within various
Seat Mounts: Anchoring Growth in the Dynamic Marine Seats Market
Seat Mounts: Anchoring Growth in the Dynamic Marine Seats Market
The marine seats market is driven by the demand for comfort, safety, and durability in various marine applications, from recreational boating to commercial vessels. Within this dynamic sector, the seat mount segment presents a high-opportunity area, playing a crucial role in ensuring secure and adaptable seating solutions for diverse marine environments. Market Dynamics and Growth Drivers Seat mounts provide the essential connection between marine seats and the vessel's deck, offering stability, adjustability,
PE100 Pipes: The High-Pressure Powerhouse Driving Growth in the HDPE Pipes Market
PE100 Pipes: The High-Pressure Powerhouse Driving Growth in the HDPE Pipes Marke …
The HDPE (High-Density Polyethylene) pipes market is experiencing robust expansion, fueled by its versatility and durability across various applications. Within this thriving sector, the PE100 pipe segment stands out as a high-opportunity area, offering superior performance for high-pressure applications in water, gas, and industrial pipelines. Market Dynamics and Growth Drivers PE100 pipes, characterized by their high density and excellent long-term hydrostatic strength, are designed to withstand demanding operating pressures

All 5 Releases


More Releases for Antihypertensive

Antihypertensive Drugs Market Future Prediction Report By 2033
The global Antihypertensive Drugs Market was valued at approximately USD 30.5 billion in 2024 and is projected to reach around USD 38.4 billion by 2033, growing at a compound annual growth rate (CAGR) of 2.6% from 2025 to 2033 . Antihypertensive Drugs Market Overview The global Antihypertensive Drugs Marke is driven by the rising global burden of hypertension, especially among the elderly and individuals with lifestyle-related risk factors such as obesity, poor
Antihypertensive Drugs Market Segmentation, and Future Growth Prospects
In recent years, the global Antihypertensive Drugs Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Antihypertensive Drugs Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five
Antihypertensive Drugs Market Size to Reach USD 10 Billion 2030
Exclusive Report by Ameco Research: Antihypertensive Drugs Market Size Projected to Reach USD 52 Billion by 2030, Growing at 4.70% CAGR Ameco Research is proud to announce the launch of its latest market research report, Antihypertensive Drugs Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research
Antihypertensive Drugs Market to Develop Rapidly by 2031, TMR Study
The global Antihypertensive Drugs Market market is estimated to attain a valuation of US$ 40 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 3% during the forecast period, 2022 to 2031. The key objective of the TMR report is to offer a complete assessment of the global market including major
Safety And Effectiveness Of First-line Antihypertensive Drug Classes
For those with extremely high blood pressure, or hypertension, there are many initial medication options -- so many that it can be hard to know which one to use. Now, a Yale-coauthored paper in Lancet provides more information about the relative safety and effectiveness of different hypertension drugs in order to inform this critical treatment decision. The study reveals that angiotensin converting enzyme (ACE) inhibitors may not be the best
Antihypertensive Drugs Market : Opportunities and Forecasts upto 2023
Human health is being affected by various factors which include rapid urbanization, demographic ageing and the globalization of unhealthy lifestyles. Hypertension is one of the keyhealth issuesthat are observed in both developed as well as developing countries. It is a silent, invisible killer that rarely causes symptoms and is one of the key risk factors forcoronary heart disease and ischemic as well as hemorrhagic stroke. Hypertension can also lead to